Petros Pharmaceuticals Files 8-K on Accountant Change
Ticker: PTPI · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1815903
| Field | Detail |
|---|---|
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, financials, filing
TL;DR
Petros Pharma changed auditors, filed financials. Watch for impact.
AI Summary
Petros Pharmaceuticals, Inc. filed an 8-K on April 9, 2025, reporting changes in its certifying accountant and filing financial statements and exhibits. The report covers events up to April 5, 2025. The company is incorporated in Delaware and its principal executive offices are located in New York.
Why It Matters
This filing indicates a change in the company's auditor, which could signal a shift in financial oversight or internal controls. Investors should monitor any subsequent financial reports for potential impacts.
Risk Assessment
Risk Level: low — The filing is a standard procedural update regarding a change in certifying accountant and the submission of financial statements, with no immediate negative financial implications disclosed.
Key Players & Entities
- Petros Pharmaceuticals, Inc. (company) — Registrant
- April 5, 2025 (date) — Date of earliest event reported
- April 9, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Address of principal executive offices
FAQ
What is the primary reason for the change in Petros Pharmaceuticals' certifying accountant?
The filing does not specify the reason for the change in certifying accountant, only that a change has occurred and financial statements and exhibits are being filed.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on April 5, 2025.
What is the SEC file number for Petros Pharmaceuticals?
The SEC file number for Petros Pharmaceuticals is 001-39752.
Where are Petros Pharmaceuticals' principal executive offices located?
Petros Pharmaceuticals' principal executive offices are located at 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036.
What type of company is Petros Pharmaceuticals, based on its SIC code?
Based on its Standard Industrial Classification (SIC) code of 2834, Petros Pharmaceuticals is in the business of Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding Petros Pharmaceuticals, Inc. (PTPI).